Published in
Springer Nature [academic journals on nature.com], Leukemia, 3(33), p. 776-780, 2018
DOI: 10.1038/s41375-018-0282-y
Links
Tools
Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study
Journal article published in 2018 by
Roch Houot,
Guillaume Cartron,
Fontanet Bijou,
Sophie de Guibert,
Gilles A. Salles 
,
Christophe Fruchart,
Krimo Bouabdallah,
Marie Maerevoet,
Pierre Feugier,
Steven Le Gouill,
Hervé Tilly,
Rene-Olivier Casasnovas ,
Cécile Moluçon-Chabrot,
Eric Van Den Neste,
Pierre Zachee
and other authors.
,
Christophe Fruchart,
Krimo Bouabdallah,
Marie Maerevoet,
Pierre Feugier,
Steven Le Gouill,
Hervé Tilly,
Rene-Olivier Casasnovas ,
Cécile Moluçon-Chabrot,
Eric Van Den Neste,
Pierre Zachee
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 